IN2014MN02418A - - Google Patents
Download PDFInfo
- Publication number
- IN2014MN02418A IN2014MN02418A IN2418MUN2014A IN2014MN02418A IN 2014MN02418 A IN2014MN02418 A IN 2014MN02418A IN 2418MUN2014 A IN2418MUN2014 A IN 2418MUN2014A IN 2014MN02418 A IN2014MN02418 A IN 2014MN02418A
- Authority
- IN
- India
- Prior art keywords
- methods
- breast cancer
- subject
- gene expression
- evaluating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261650209P | 2012-05-22 | 2012-05-22 | |
| US201361753673P | 2013-01-17 | 2013-01-17 | |
| PCT/US2013/042157 WO2013177245A2 (en) | 2012-05-22 | 2013-05-22 | Nano46 genes and methods to predict breast cancer outcome |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN02418A true IN2014MN02418A (uk) | 2015-08-14 |
Family
ID=49624503
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2418MUN2014 IN2014MN02418A (uk) | 2012-05-22 | 2013-05-22 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20130337444A1 (uk) |
| EP (1) | EP2852689B1 (uk) |
| JP (1) | JP6325530B2 (uk) |
| CN (2) | CN111500718A (uk) |
| AU (1) | AU2013266419B2 (uk) |
| BR (1) | BR112014029300A2 (uk) |
| CA (1) | CA2874492C (uk) |
| ES (1) | ES2763931T3 (uk) |
| IL (1) | IL235795B (uk) |
| IN (1) | IN2014MN02418A (uk) |
| MX (1) | MX369628B (uk) |
| WO (1) | WO2013177245A2 (uk) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009158143A1 (en) | 2008-05-30 | 2009-12-30 | The University Of North Carolina At Chapel Hill | Gene expression profiles to predict breast cancer outcomes |
| US9066963B2 (en) | 2011-03-15 | 2015-06-30 | The University Of North Carolina At Chapel Hill | Methods of treating breast cancer with anthracycline therapy |
| GB201106254D0 (en) | 2011-04-13 | 2011-05-25 | Frisen Jonas | Method and product |
| AU2012345789B2 (en) | 2011-11-30 | 2018-02-15 | British Columbia Cancer Agency Branch | Methods of treating breast cancer with taxane therapy |
| EP3901280A1 (en) | 2012-10-17 | 2021-10-27 | Spatial Transcriptomics AB | Methods and product for optimising localised or spatial detection of gene expression in a tissue sample |
| WO2014186349A1 (en) * | 2013-05-13 | 2014-11-20 | Nanostring Technologies, Inc. | Methods to predict risk of recurrence in node-positive early breast cancer |
| EP4234716A3 (en) | 2013-06-25 | 2023-12-06 | Prognosys Biosciences, Inc. | Methods for determining spatial patterns of biological targets in a sample |
| CA2923166A1 (en) | 2013-09-09 | 2015-03-12 | British Columbia Cancer Agency Branch | Methods and kits for predicting outcome and methods and kits for treating breast cancer with radiation therapy |
| AU2015349870B2 (en) | 2014-11-21 | 2019-09-26 | Bruker Spatial Biology, Inc. | Enzyme- and amplification-free sequencing |
| EP3223947B1 (en) * | 2014-11-24 | 2019-10-30 | Nanostring Technologies, Inc. | Methods and apparatuses for gene purification and imaging |
| JP2018500895A (ja) * | 2014-12-09 | 2018-01-18 | キングス・カレッジ・ロンドン | タキサン療法による乳癌治療 |
| CA2982146A1 (en) | 2015-04-10 | 2016-10-13 | Spatial Transcriptomics Ab | Spatially distinguished, multiplex nucleic acid analysis of biological specimens |
| CN107850599B (zh) * | 2015-07-23 | 2021-02-09 | 新加坡国立大学 | Wbp2与her2作为共预后因子对患者分层以进行治疗 |
| KR102490693B1 (ko) | 2016-05-16 | 2023-01-19 | 나노스트링 테크놀로지스, 인크. | 샘플 중 표적 핵산을 검출하는 방법 |
| WO2017222453A1 (en) | 2016-06-21 | 2017-12-28 | Hauling Thomas | Nucleic acid sequencing |
| WO2018074865A2 (ko) * | 2016-10-21 | 2018-04-26 | 서울대학교병원 | 유방암 예후 예측용 조성물 및 방법 |
| KR102476709B1 (ko) | 2016-11-21 | 2022-12-09 | 나노스트링 테크놀로지스, 인크. | 화학적 조성물 및 이것을 사용하는 방법 |
| KR101950717B1 (ko) * | 2016-11-23 | 2019-02-21 | 주식회사 젠큐릭스 | 유방암 환자의 화학치료 유용성 예측 방법 |
| US11978535B2 (en) * | 2017-02-01 | 2024-05-07 | The Translational Genomics Research Institute | Methods of detecting somatic and germline variants in impure tumors |
| CA3078158A1 (en) | 2017-10-06 | 2019-04-11 | Cartana Ab | Rna templated ligation |
| KR102071491B1 (ko) * | 2017-11-10 | 2020-01-30 | 주식회사 디시젠 | 차세대 염기서열분석을 이용한 기계학습 기반 유방암 예후 예측 방법 및 예측 시스템 |
| AU2019271028A1 (en) | 2018-05-14 | 2020-12-03 | Bruker Spatial Biology, Inc. | Chemical compositions and methods of using same |
| US20210371936A1 (en) * | 2018-11-05 | 2021-12-02 | Biontech Diagnostics Gmbh | Predictive methods in breast cancer |
| CA3139791A1 (en) | 2019-05-31 | 2020-12-03 | 10X Genomics, Inc. | Method of detecting target nucleic acid molecules |
| JP7352937B2 (ja) * | 2019-07-19 | 2023-09-29 | 公立大学法人福島県立医科大学 | 乳癌のサブタイプを鑑別又は分類するための鑑別マーカー遺伝子セット、方法およびキット |
| EP3945136A1 (en) * | 2020-07-28 | 2022-02-02 | Hospital Clínic de Barcelona | In vitro method for the prognosis of patients suffering from her2-positive breast cancer |
| US12060603B2 (en) | 2021-01-19 | 2024-08-13 | 10X Genomics, Inc. | Methods for internally controlled in situ assays using padlock probes |
| AU2022419002A1 (en) * | 2021-12-20 | 2024-08-01 | Fundació De Recerca Clínic Barcelona-Institut D’Investigacions Biomèdiques August Pi I Sunyer | Development and validation of an in vitro method for the prognosis of patients suffering from her2-positive breast cancer |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5800992A (en) | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
| US6040138A (en) | 1995-09-15 | 2000-03-21 | Affymetrix, Inc. | Expression monitoring by hybridization to high density oligonucleotide arrays |
| CA2118806A1 (en) | 1991-09-18 | 1993-04-01 | William J. Dower | Method of synthesizing diverse collections of oligomers |
| US5384261A (en) | 1991-11-22 | 1995-01-24 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis using mechanically directed flow paths |
| US5677195A (en) | 1991-11-22 | 1997-10-14 | Affymax Technologies N.V. | Combinatorial strategies for polymer synthesis |
| US5856174A (en) | 1995-06-29 | 1999-01-05 | Affymetrix, Inc. | Integrated nucleic acid diagnostic device |
| EP0880598A4 (en) | 1996-01-23 | 2005-02-23 | Affymetrix Inc | RAPID EVALUATION OF NUCLEIC ACID ABUNDANCE DIFFERENCE, WITH A HIGH-DENSITY OLIGONUCLEOTIDE SYSTEM |
| DE69829402T2 (de) | 1997-10-31 | 2006-04-13 | Affymetrix, Inc. (a Delaware Corp.), Santa Clara | Expressionsprofile in adulten und fötalen organen |
| US6020135A (en) | 1998-03-27 | 2000-02-01 | Affymetrix, Inc. | P53-regulated genes |
| US6750015B2 (en) * | 2000-06-28 | 2004-06-15 | Kathryn B. Horwitz | Progesterone receptor-regulated gene expression and methods related thereto |
| US20020168639A1 (en) * | 2000-09-22 | 2002-11-14 | Muraca Patrick J. | Profile array substrates |
| DK3170906T3 (en) | 2003-06-24 | 2018-11-05 | Genomic Health Inc | PREDICTION OF THE LIKELI REVENUE OF CANCER |
| EP2469439A2 (en) * | 2003-09-29 | 2012-06-27 | Pathwork Diagnostics, Inc. | Systems and methods for detecting biological features |
| US20080032293A1 (en) | 2004-07-15 | 2008-02-07 | The University Of North Carolina At Chapel Hill | Housekeeping Genes And Methods For Identifying Same |
| CN101057144A (zh) * | 2004-09-22 | 2007-10-17 | 三路影像公司 | 用于评价乳腺癌预后的方法和组合物 |
| CA2630974A1 (en) | 2005-11-23 | 2007-05-31 | University Of Utah Research Foundation | Methods and compositions involving intrinsic genes |
| CA2640385C (en) | 2005-12-23 | 2014-07-15 | Nanostring Technologies, Inc. | Nanoreporters and methods of manufacturing and use thereof |
| WO2007076132A2 (en) | 2005-12-23 | 2007-07-05 | Nanostring Technologies, Inc. | Compositions comprising oriented, immobilized macromolecules and methods for their preparation |
| WO2008124847A2 (en) | 2007-04-10 | 2008-10-16 | Nanostring Technologies, Inc. | Methods and computer systems for identifying target-specific sequences for use in nanoreporters |
| WO2008150512A2 (en) * | 2007-06-04 | 2008-12-11 | University Of Louisville Research Foundation, Inc. | Methods for identifying an increased likelihood of recurrence of breast cancer |
| ES2618353T3 (es) * | 2007-09-06 | 2017-06-21 | Biotheranostics, Inc. | Clasificación de tumores y pronóstico del cáncer de mama |
| WO2009158143A1 (en) * | 2008-05-30 | 2009-12-30 | The University Of North Carolina At Chapel Hill | Gene expression profiles to predict breast cancer outcomes |
| EP2331704B1 (en) | 2008-08-14 | 2016-11-30 | Nanostring Technologies, Inc | Stable nanoreporters |
| PL2845911T3 (pl) * | 2010-03-31 | 2017-01-31 | Sividon Diagnostics Gmbh | Sposób przewidywania nawrotu raka sutka podczas leczenia endokrynologicznego |
-
2013
- 2013-05-22 WO PCT/US2013/042157 patent/WO2013177245A2/en active Application Filing
- 2013-05-22 MX MX2014014275A patent/MX369628B/es active IP Right Grant
- 2013-05-22 CN CN201911216650.9A patent/CN111500718A/zh active Pending
- 2013-05-22 BR BR112014029300A patent/BR112014029300A2/pt not_active Application Discontinuation
- 2013-05-22 ES ES13794236T patent/ES2763931T3/es active Active
- 2013-05-22 CA CA2874492A patent/CA2874492C/en active Active
- 2013-05-22 JP JP2015514143A patent/JP6325530B2/ja active Active
- 2013-05-22 AU AU2013266419A patent/AU2013266419B2/en active Active
- 2013-05-22 CN CN201380038875.4A patent/CN104704128A/zh active Pending
- 2013-05-22 EP EP13794236.3A patent/EP2852689B1/en active Active
- 2013-05-22 IN IN2418MUN2014 patent/IN2014MN02418A/en unknown
- 2013-05-22 US US13/899,656 patent/US20130337444A1/en not_active Abandoned
-
2014
- 2014-11-20 IL IL235795A patent/IL235795B/en active IP Right Grant
-
2020
- 2020-02-14 US US16/792,051 patent/US20200332368A1/en not_active Abandoned
-
2022
- 2022-09-29 US US17/936,745 patent/US20230272476A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2013266419A1 (en) | 2014-12-11 |
| EP2852689A4 (en) | 2016-05-11 |
| IL235795A0 (en) | 2015-01-29 |
| ES2763931T3 (es) | 2020-06-01 |
| CA2874492C (en) | 2021-10-19 |
| CN104704128A (zh) | 2015-06-10 |
| US20200332368A1 (en) | 2020-10-22 |
| JP2015518724A (ja) | 2015-07-06 |
| AU2013266419B2 (en) | 2018-09-27 |
| WO2013177245A2 (en) | 2013-11-28 |
| MX2014014275A (es) | 2015-07-06 |
| CN111500718A (zh) | 2020-08-07 |
| CA2874492A1 (en) | 2013-11-28 |
| US20130337444A1 (en) | 2013-12-19 |
| IL235795B (en) | 2020-02-27 |
| MX369628B (es) | 2019-11-14 |
| BR112014029300A2 (pt) | 2017-07-25 |
| EP2852689B1 (en) | 2019-12-11 |
| EP2852689A2 (en) | 2015-04-01 |
| WO2013177245A3 (en) | 2015-01-29 |
| JP6325530B2 (ja) | 2018-05-16 |
| US20230272476A1 (en) | 2023-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014MN02418A (uk) | ||
| CY1114993T1 (el) | Προφιλ εκφρασης γονιδιου για να προβλεπονται εκβασεις καρκινου μαστου | |
| EA201390762A1 (ru) | Новые биомаркеры для предсказания исхода противораковой иммунотерапии | |
| MX2019007814A (es) | Algoritmo de perfil de expresion genica y prueba para determinar la prognosis de cancer de prostata. | |
| MX2020001156A (es) | Metodo para el pronostico y tratamiento de metastasis de cancer. | |
| NZ599194A (en) | Methods to predict clinical outcome of cancer | |
| MX2019000091A (es) | Metodo para el pronostico y tratamiento de cancer metastasico de los huesos originado de cancer de mama. | |
| WO2010051314A3 (en) | Genomic classification of non-small cell lung carcinoma based on patterns of gene copy number alterations | |
| PH12014502410A1 (en) | Breast cancer prognosis, prediction of progesterone receptor subtype and|prediction of response to antiprogestin treatment based on gene expression | |
| NZ621638A (en) | Dna methylation in colorectal and breast cancer diagnostic methods | |
| WO2011153545A3 (en) | Gene expression signature as a predictor of chemotherapeutic response in breast cancer | |
| CY1117838T1 (el) | Παραγοντες προβλεψης για θεραπευτικη αγωγη καρκινου | |
| WO2014184679A3 (en) | Method for the prognosis and treatment of renal cell carcinoma metastasis | |
| MX2013008252A (es) | Firma de pronostico para la recurrencia de cancer colorrectal. | |
| BR112015022977A2 (pt) | métodos para predição de risco de metástase em melanoma cutâneo | |
| Montserrat et al. | Present and future of personalized medicine in CLL | |
| MX2016012718A (es) | Determinación de polimorfismos de un solo nucleótido útil para predecir la respuesta para rasagilina. | |
| WO2014023808A3 (en) | Method for evaluating a cancer patient for propensity to respond to a therapy | |
| RU2010149541A (ru) | Способ прогнозирования развития метаболического синдрома у пациента с абдоминальным ожирением | |
| MX2017004816A (es) | Métodos para predecir resultados clínicos en sujetos afectados con colitis ulcerosa. | |
| RU2012140862A (ru) | Способ прогнозирования риска возникновения переломов | |
| UA108260U (uk) | Спосіб прогнозування розвитку остеопорозу | |
| WO2011133500A3 (en) | Detection and analysis of epigenetic and genetic changes in tumor tissue | |
| UA95616U (uk) | Спосіб прогнозування зрощення перелому | |
| Salmoiraghi et al. | Next Generation Sequencing (NGS) of TP53 Gene Allows to Identify a Very High Risk Group of Philadelphia Negative Acute Lymphoblastic Leukemia (ALL) Patients |